Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Oh, Chung Sik ^a   Rhee, Ka Young ^a   Yoon, Tae Gyoon ^a   Woo, Nam Sik ^a   Hong, Seung Wan ^a   Kim, Seong Hyop ^a,b  

^a Konkuk University Hospital   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NEOSTIGMINE; SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); EXTUBATION; FEMALE; FRACTURE TREATMENT; GENERAL ANESTHESIA; HIP FRACTURE; HIP SURGERY; HUMAN; HYPOXIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROMUSCULAR BLOCKING; POSTOPERATIVE DELIRIUM; POSTOPERATIVE HEMORRHAGE; RESPIRATORY FAILURE; CLINICAL TRIAL; DELIRIUM; HIP FRACTURES; POSTOPERATIVE COMPLICATIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DELIRIUM; GAMMA-CYCLODEXTRINS; HIP FRACTURES; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS;

EID: 84960968692     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/1054597     Document Type: Article

References (36)

1. M. Zlowodzki, P. Tornetta III, G. Haidukewych et al. , "Femoral neck fractures: evidence versus beliefs about predictors of outcome," Orthopedics, vol. 32, no. 4, 2009.
2. N. B. Foss and H. Kehlet, "Mortality analysis in hip fracture patients: implications for design of future outcome trials," British Journal of Anaesthesia, vol. 94, no. 1, pp. 24-29, 2005.
3. L. Krenk and L. S. Rasmussen, "Postoperative delirium and postoperative cognitive dysfunction in the elderly-what are the differences"Minerva Anestesiologica, vol. 77, no. 7, pp. 742-749, 2011.
4. M. G. Zywiel, A. Prabhu, A. V. Perruccio, and R. Gandhi, "The influence of anesthesia and pain management on cognitive dysfunction after joint arthroplasty: a systematic review," Clinical Orthopaedics and Related Research, vol. 472, no. 5, pp. 1453-1466, 2014.
5. E. W. Ely, A. Shintani, B. Truman et al. , "Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit," The Journal of the AmericanMedical Association, vol. 291, no. 14, pp. 1753-1762, 2004.
6. G. L. Bryson and A. Wyand, "Evidence-based clinical update: general anesthesia and the risk of delirium and postoperative cognitive dysfunction," Canadian Journal of Anesthesia, vol. 53, no. 7, pp. 669-677, 2006.
7. B. Plaud, B. Debaene,F. Donati, andJ. Marty, "Residual paralysis after emergence fromanesthesia," Anesthesiology, vol. 112, no. 4, pp. 1013-1022, 2010.
8. G. S. Murphy, J. W. Szokol, J. H. Marymont, S. B. Greenberg,M. J. Avram, and J. S. Vender, "Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit," Anesthesia and Analgesia, vol. 107, no. 1, pp. 130-137, 2008.
9. T. Fuchs-Buder, C. Meistelman, and J. Raft, "Sugammadex: clinical development and practical use," Korean Journal of Anesthesiology, vol. 65, pp. 495-500, 2013.
10. T. Ledowski, L. Falke, F. Johnston et al. , "Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal," European Journal of Anaesthesiology, vol. 31, no. 8, pp. 423-429, 2014.
11. T. Ledowski, S. Hillyard, B. O'Dea, R. Archer, F.-B. Vilas, and B. Kyle, "Introduction of sugammadex as standard reversal agent: impact on the incidence of residual neuromuscular blockade and postoperative patient outcome," Indian Journal of Anaesthesia, vol. 57, no. 1, pp. 46-51, 2013.
12. L. A. Steiner, "Postoperative delirium. Part 1. Pathophysiology and risk factors," European Journal of Anaesthesiology, vol. 28, no. 9, pp. 628-636, 2011.
13. J. S. Seaman, J. Schillerstrom, D. Carroll, and T. M. Brown, "Impaired oxidative metabolism precipitates delirium: a study of 101 ICU patients," Psychosomatics, vol. 47, no. 1, pp. 56-61, 2006.
14. G. V. Kumar,A. P. Nair, H. S. Murthy,K. R. Jalaja, K. Ramachandra, and G. Parameshwara, "Residual neuromuscular blockade affects postoperative pulmonary function," Anesthesiology, vol. 117, no. 6, pp. 1234-1244, 2012.
15. G. S. Murphy and S. J. Brull, "Residual neuromuscular block: lessons unlearned. Part I. Definitions, incidence, and adverse physiologic effects of residual neuromuscular block," Anesthesia and Analgesia, vol. 111, no. 1, pp. 120-128, 2010.
16. C. F. Minto, T. W. Schnider, T. D. Egan et al. , "Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil I. Model development," Anesthesiology, vol. 86, no. 1, pp. 10-23, 1997.
17. A. F. Kopman, P. S. Yee, and G. G. Neuman, "Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers," Anesthesiology, vol. 86, no. 4, pp. 765-771, 1997.
18. S. K. Inouye, C. H. VanDyck, C. A. Alessi, S. Balkin,A. P. Siegal, and R. I. Horwitz, "Clarifying confusion: the confusion assessment method: a new method for detection of delirium," Annals of Internal Medicine, vol. 113, no. 12, pp. 941-948, 1990.
19. L. McNicoll,M. A. Pisani,E. W. Ely,D. Gifford, andS. K. Inouye, "Detection of delirium in the intensive care unit: comparison of confusion assessment method for the intensive care unit with confusion assessment method ratings," Journal of the American Geriatrics Society, vol. 53, no. 3, pp. 495-500, 2005.
20. C. B. Dyer, C. M. Ashton, and T. A. Teasdale, "Postoperative delirium. A review of 80 primary data-collection studies," Archives of Internal Medicine, vol. 155, no. 5, pp. 461-465, 1995.
21. G. Simonneau, A. Vivien,R. Sartene et al. , "Diaphragmdysfunction induced by upper abdominal surgery. Role of postoperative pain,"American Reviewof RespiratoryDisease, vol. 128, no. 5,pp. 899-903, 1983.
22. H. Berg, J. Roed, J. Viby-Mogensen et al. , "Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium," Acta Anaesthesiologica Scandinavica, vol. 41, no. 9, pp. 1095-1103, 1997.
23. J. R. Maldonado, "Delirium in the acute care setting: characteristics, diagnosis and treatment," Critical Care Clinics, vol. 24,no. 4, pp. 657-722, 2008.
24. J. R. Maldonado, "Neuropathogenesis of delirium: review of current etiologic theories and common pathways," The American Journal of Geriatric Psychiatry, vol. 21, no. 12, pp. 1190-1222, 2013.
25. H. D. de Boer, J. van Egmond, F. van de Pol, A. Bom, J. J. Driessen, and L. H. D. J. Booij, "Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation," British Journal of Anaesthesia, vol. 97, no. 5, pp. 681-686, 2006.
26. V. A. Lawrence, S. G. Hilsenbeck, H. Noveck, R. M. Poses, and J. L. Carson, "Medical complications and outcomes after hip fracture repair," Archives of Internal Medicine, vol. 162, no. 18, pp. 2053-2057, 2002.
27. P. Amorim, F. Lagarto, B. Gomes et al. , "Neostigmine vs. sugammadex: observational cohort study comparing the quality of recovery using the Postoperative Quality Recovery Scale," Acta Anaesthesiologica Scandinavica, vol. 58,no. 9, pp. 1101-1110,2014.
28. P. T. Trzepacz, "Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine," Seminars in Clinical Neuropsychiatry, vol. 5, no. 2, pp. 132-148, 2000.
29. W. T. Nicholson, J. Sprung, and C. J. Jankowski, "Sugammadex: a novel agent for the reversal of neuromuscular blockade," Pharmacotherapy, vol. 27, no. 8, pp. 1181-1188, 2007.
30. J. Lin, J. J. Freeman, and J. W. Kosh, "Antagonism of acute physostigmine and neostigmine toxicity in mice by hemicholinium-3," Research Communications in Chemical Pathology and Pharmacology, vol. 56, no. 1, pp. 137-140, 1987.
31. S. L. Hail, A. Obafemi, and K. C. Kleinschmidt, "Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient," Clinical Toxicology, vol. 51, no. 3, pp. 162-166, 2013.
32. A. Lankarani-Fard and S. C. Castle, "Postoperative deliriumand Ogilvie's syndrome resolving with neostigmine," Journal of the American Geriatrics Society, vol. 54, no. 6, pp. 1016-1017, 2006.
33. A. R. Moore and S. T. O'Keeffe, "Drug-induced cognitive impairment in the elderly," Drugs and Aging, vol. 15, no. 1, pp. 15-28, 1999.
34. S. E. Molchan, R. A. Martinez, J. L. Hill et al. , "Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model," Brain Research Reviews, vol. 17, no. 3, pp. 215-226, 1992.
35. E. Sundman, H. Witt, R. Olsson, O. Ekberg, R. Kuylenstierna, and L. I. Eriksson, "The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium," Anesthesiology, vol. 92, no. 4, pp. 977-984, 2000.
36. A. Baraka, J. P. Yared, A. M. Karam, and A. Winnie, "Glycopyrrolate-neostigmine and atropine-neostigmine mixtures affect postanesthetic arousal times differently," Anesthesia and Analgesia, vol. 59, no. 6, pp. 431-434, 1980.